Anticonvulsants
Vimpat (lacosamide) was switched from a non-preferred to a preferred agent for the treatment of seizures.

Antidepressants, Other
Effexor XR (venlafaxine) is now a preferred agent and venlafaxine ER capsules have been switched from preferred to non-preferred.

Bronchodilators
Proventil HFA is now a preferred agent and Ventolin HFA is now a non-preferred agent.  Maxair and ProAir HFA remain preferred agents.

Intranasal Rhinitis Agents
Multiple drugs switched from non-preferred to preferred status: Astepro, Patanase, Beconase AQ, flunisolide, and Nasacort AQ.

Ophthalmic Antibiotic-Steroid Combinations
New class of drugs on the PDL.  Preferred agents are: Blephamide (sulfacetamide/prednisolone), neomycin/polymyxin/dexamethasone, Pred-G (gentamicin/prednisolone), sulfacetamide/prednisolone, Tobradex ointment, tobramycin/dexamethasone, and Zylet (loteprednol/tobramycin).

Otic Anti-Infectives and Anesthetics
New class of drugs on the PDL.  Preferred agents that do not require prior authorization are otic acetic acid and acetic acid/aluminum.  The non-preferred agent that requires trial and failure of a preferred agent is otic acetic acid/hydrocortisone.